Clinical Trial Update: Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial investigating methylphenidate, modafinil, and amantadine for fatigue in multiple sclerosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue in Multiple Sclerosis
• Multiple Sclerosis

Drugs mentioned

• Methylphenidate (Methylphenidate)
• Modafinil (modafinil)
• amantadine (amantadine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Fatigue in Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2020-10-19